Key result
AF is linked to significant cognitive impairment, but the long-term impact of treatments remains unknown.
Why the study?
Atrial fibrillation is recognized as a risk factor for significant cognitive impairment beyond thromboembolic risk, but the impact of interventions on long-term cognitive function is unclear.
Do interventions such as anticoagulation and rhythm control have a beneficial effect on long-term cognitive function in patients with atrial fibrillation?
Do interventions such as anticoagulation and rhythm control have a beneficial effect on long-term cognitive function in patients with atrial fibrillation?
Atrial fibrillation is increasingly recognized as a risk factor for cognitive impairment, highlighting the need for future studies to determine if AF therapies can protect long-term cognitive function.
AF increasingly linked to cognitive impairment; leaves open whether anticoagulation or rhythm control preserves long-term function.
Growing evidence suggests that atrial fibrillation (AF), in addition to known thromboembolic risk, is a risk factor for significant cognitive impairment via several pathways, further contributing to morbidity and mortality. Whether anticoagulation, rhythm control strategies and other interventions aiming at preventing thromboembolic events and ameliorating the clinical outcome of AF patients, may also have a beneficial effect on long-term cognitive function remains to be seen in future studies.
No takes yet. Share an insight, caveat, or question.
Antonis S. Manolis (2015) conducted a review in Atrial Fibrillation and Cognitive Impairment. Atrial fibrillation was evaluated on Cognitive impairment. Atrial fibrillation is increasingly recognized as a risk factor for significant cognitive impairment, though the impact of treatments on long-term cognitive function remains to be established.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: